Present article focuses on various lipoprotein based drug delivery vehicles used in cancer and tumor therapeutics. Starting from aqueous phase delivery through liposomes or unilamellar vesicles, biomimetic HDL nanoparticles, discoidal recombinant high-density lipoproteins (d-rHDLs) are favorably used to deliver anticancer agents. LDL based carrier vehicles are reconstituted in many ways i.e. discoidal SMAaf-based lipid nanoparticles, nanovectors, LDL nanoparticles, SiRNA-HDL used for systemic delivery of short interfering RNA. This article also explains chemically and genetically engineered highdensity lipoprotein (HDL)-like nanodiscs or "bicelles", chylomicrons, and monoclonal antibodies and ligand-coupled lipoprotein as drug delivery vehicles. These are most promising delivery systems for anticancer drugs. Acetylated low-density lipoprotein is also used as a delivery vehicle for anti-infectious drugs. There is immense need of therapies, imaging agents, and drug delivery vehicles to combat rising number of cases of neoplasticity and tumors in population. For safe cancer therapeutics nano-sized sitespecific drug delivery vehicles which might show bio-compatibility, bio-degradability, and receptor-mediated endocytosis are to be developed.